10x Genomics, Inc. TXG Consumables — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s consumables — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s consumables — revenue?
- 10x Genomics, Inc. (TXG) reported consumables — revenue of $129.8M in Q1 2026.
- How has 10x Genomics, Inc.'s consumables — revenue changed year-over-year?
- 10x Genomics, Inc.'s consumables — revenue increased by 12.5% year-over-year, from $115.36M to $129.8M.
- What is the long-term trend for 10x Genomics, Inc.'s consumables — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s consumables — revenue has grown at a 4.9% compound annual growth rate (CAGR), from $418.74M to $507.18M.
- What does consumables — revenue mean?
- This metric represents the total revenue generated from the sale of recurring, single-use products required to operate the company's core analytical instruments. It serves as a key indicator of the installed base utilization and the long-term recurring revenue potential of the company's life science technology ecosystem. Growth in this segment typically reflects increasing adoption and active usage of the company's platforms by research and clinical customers.